<i>Estimated metabolic rates among the simulation workflows</i>. by Israel Luis (13916706)

Average kidney and heart weight of rats. by Diana Bylan (20421873)

“…Dose-dependent experiments showed that COE (1 and 2μg/ml) induced a significant increase of phospho-(S473)-AKT along with a decrease in phospho (T180 + Y182) P38 levels.…”

<b>Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate:</b> <b>A Randomized Trial</b> by Siham Abdelgani (17756772)

Data Sheet 1_Assessing the efficacy and safety of pentoxifylline in preventing chemotherapy-induced peripheral neuropathy and mucositis in breast cancer patients.pdf by Samar A. Dewidar (22425457)

“…</p>Conclusion<p>The co-administration of PTX with AC/T chemotherapy in breast cancer patients significantly decreases the incidence and postpones the onset of grade 2 or higher peripheral neuropathy and the incidence of mucositis without causing additional risks for the patients.…”

The lag phase defect is specific to transitions that require the production of FA, and correlates with FA concentration. by Zachary T. Hying (21512605)

Shell colour luminance variation of five phenotypic groups according to background colour categories of <i>Polymita picta</i>. by Mario Juan Gordillo-Pérez (20565248)

PERCOM, an unbiased and easily-accessible protein-centric analysis workflow. by Brian Foo (19273132)

LA has minimal impact on HIV-1 virion integrity and surface levels of gp120 envelope protein. by Muriel Aldunate (22411177)

Shell colour luminance variation of six phenotypic groups according to background colour and spiral band categories of <i>Polymita muscarum</i>. by Mario Juan Gordillo-Pérez (20565248)

The presence of lanthanum minimizes the lag phase and FA imbalance during the transition from formate to MeOH. by Zachary T. Hying (21512605)

Anti-cancer effect of TC extract on MMNK1 cell line. by Napat Armartmuntree (20571035)

Virucidal activity of vaginal acids against HSV-2 and HPV-16. by Muriel Aldunate (22411177)

PTSD symptom changes during Trauma-Focused Cognitive Behavioural Therapy (TF-CBT) in children and adolescents: a Single-Case Experimental Design study by Lieke H. Kooij (12895939)

“…However, symptoms do not decrease in a clear line, and individual symptom fluctuations are common.…”

ExaF contributes to FA homeostasis by lowering the FA concentration. by Zachary T. Hying (21512605)

Data Sheet 1_Electroacupuncture treatment can improve cognitive impairment in spontaneously hypertensive rats: a preliminary DTI study.docx by Ji-peng Liu (14764009)

“…Background<p>Hypertension is a significant risk factor for cognitive impairment. …”

Degradation of virion-associated RNA following acid treatment. by Muriel Aldunate (22411177)

Analysis of L-LA on gp120 protein conformation and rCD4 binding. by Muriel Aldunate (22411177)

Virucidal activity of equimolar levels of the protonated form of vaginal LA, SCFAs, and succinic acid. by Muriel Aldunate (22411177)

Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”